Exclusive: Pfizer explores sale of hospital drugs unit, sources say
Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter.
The hospital unit was itself the result of a major acquisition, formed after Pfizer shelled out $17 billion to purchase ...
The scalable platform can be initially deployed, and later upgraded to include Hospira MedNet™ safety software to meet your evolving patient care needs. The unique, innovative PlumSet ...
Hospira has proven that biosimilar companies can make mistakes every bit as foolish as companies with originator products, after having arranged a lavish foreign trip for NHS pharmacists.
But his job took an unexpected turn in 2010, when Hospira, the maker of the drug sodium thiopental, stopped production in the US due to an unspecified issue with obtaining raw materials.
Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software, and ...
Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...
The unit, now called Pfizer Hospital, was formed after Pfizer bought Hospira for about $17B in 2015. The pharma giant has hired Goldman Sachs (GS) to gauge initial interest from potential buyers, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback